Skip to main content

Latest SEC Filings — Page 40

Most recent SEC EDGAR filings across all covered tickers, sorted chronologically. Wiseek AI reads each filing and scores it 1–10 for market-moving potential; click through for full analysis.

CRWD filing
Form 4CRWD · Form 4 · 22h ago
Meta Reports Strong Q1 Earnings Amidst Escalating Multi-Billion Dollar Legal Liabilities and Aggressive AI Investments
ProForm 10-QMETA · Form 10-Q · 22h ago
IBRX filing
Form DEFA14AIBRX · Form DEFA14A · 22h ago
Proxy Statement Details Shareholder Meeting, Executive Pay, and Significant Related-Party Convertible Debt
Form DEF 14AIBRX · Form DEF 14A · 22h ago
Anika Therapeutics Details Q1 Financials, Revealing Increased Cash Burn and Restructuring Costs
Form 10-QANIK · Form 10-Q · 22h ago
CPSS filing
Form 4CPSS · Form 4 · 22h ago
HIPO filing
Form 4HIPO · Form 4 · 22h ago
BMO filing
Form FWPBMO · Form FWP · 22h ago
BMO filing
Form FWPBMO · Form FWP · 22h ago
BMO filing
Form FWPBMO · Form FWP · 22h ago
BMO filing
Form FWPBMO · Form FWP · 22h ago
VINP filing
Form 4VINP · Form 4 · 22h ago
BMO filing
Form FWPBMO · Form FWP · 22h ago
VINP filing
Form 4VINP · Form 4 · 22h ago
BMO filing
Form FWPBMO · Form FWP · 22h ago
BMO filing
Form FWPBMO · Form FWP · 22h ago
BMO filing
Form FWPBMO · Form FWP · 22h ago
SGMO filing
Form 10-K/ASGMO · Form 10-K/A · 22h ago
Q1 Earnings Miss: Profitability Plummets Amid Operational Headwinds and Rising Legal Costs
ProForm 8-KPPC · Form 8-K · 22h ago
PPC filing
Form 8-KPPC · Form 8-K · 22h ago
CEO Matt Ehrlichman Updates 21.8% Stake in Porch Group, Details Recent Equity Awards
Form SCHEDULE 13D/APRCH · Form SCHEDULE 13D/A · 22h ago
MEOH filing
Form 6-KMEOH · Form 6-K · 22h ago
PDFS filing
Form DEFA14APDFS · Form DEFA14A · 22h ago
RVLV filing
Form 4RVLV · Form 4 · 22h ago
RVLV filing
Form 4RVLV · Form 4 · 22h ago
RVLV filing
Form 4RVLV · Form 4 · 22h ago
Zenas BioPharma CEO Buys Over $1 Million in Company Stock
Form 4ZBIO · Form 4 · 22h ago
HOWL filing
Form 4HOWL · Form 4 · 23h ago
CM filing
Form FWPCM · Form FWP · 23h ago
Vivos Therapeutics Registers 3.96M Shares for Resale by Armistice Capital, Signaling Potential 29% Dilution Amidst Financial Distress
Form S-3/AVVOS · Form S-3/A · 23h ago